Summary of Key Information:
Reporting Period: Quarter and Half-Year ended September 30, 2026 (Q2 FY27, H1 FY27)
Nature of Filing / Announcement: Regulatory filing pursuant to SEBI Listing Regulations 30, 33, 51, and 52
Date of Board Meeting / Approval: November 7, 2026 (Meeting held from 2:00 PM to 4:40 PM IST)
Audit Opinion: Unmodified opinion for standalone results; Limited review report for consolidated results
Auditor's Comment: The limited review report for consolidated results includes qualifications regarding unreviewed financial information of joint ventures representing a share of net loss of ₹3 crore for the quarter and ₹29 crore for the half-year.
Key Financial Highlights [All figures in ₹ crore]
Consolidated Results:
Quarter Ended September 30, 2026:
- Revenue from Operations: 4,177 (vs 3,877 in Q2 FY25, +7.7% YoY; vs 4,255 in Q1 FY26, -1.8% QoQ)
- Total Income: 4,272
- Net Profit/(Loss): (50) (vs 154 profit in Q2 FY25; vs 60 profit in Q1 FY26)
- EPS: (1.96)* (not annualized)
Half-Year Ended September 30, 2026:
- Revenue from Operations: 8,432 (vs 7,596 in H1 FY25, +11.0% YoY)
- Total Income: 8,583
- Net Profit: 10 (vs 470 in H1 FY25, -97.9% YoY)
- EPS: 0.39* (not annualized)
- Other Equity: 21,920
- Cash and Cash Equivalents: 556
- Total Debt: 7,762 (Non-current borrowings + Current borrowings including leases)
Standalone Results:
Quarter Ended September 30, 2026:
- Revenue from Operations: 1,303 (vs 1,204 in Q2 FY25, +8.2% YoY; vs 1,281 in Q1 FY26, +1.7% QoQ)
- Total Income: 1,357
- Net Profit: 122 (vs 178 in Q2 FY25, -31.5% YoY; vs 343 in Q1 FY26, -64.4% QoQ)
- EPS: 4.79* (not annualized)
Half-Year Ended September 30, 2026:
- Revenue from Operations: 2,584 (vs 2,373 in H1 FY25, +8.9% YoY)
- Total Income: 2,854
- Net Profit: 465 (vs 485 in H1 FY25, -4.1% YoY)
- EPS: 18.25* (not annualized)
- Other Equity: 20,220
- Cash and Cash Equivalents: 12
- Total Debt: 3,476 (Non-current borrowings + Current borrowings including leases)
Segment-wise Performance [₹ crore]:
The Group has reorganized its reportable operating segments effective April 1, 2026, into three sustainability-led, application-focused businesses:
Consolidated Segment Revenue Q2 FY26:
- Living Essentials: 1,191
- Industrial Essentials: 2,262
- Farm Essentials: 858
- Total Segment Revenue: 4,311
- Less: Inter-segment revenue: 134
- Revenue from Operations: 4,177
Consolidated Segment Results Q2 FY26:
- Living Essentials Profit: 85
- Industrial Essentials Loss: (120)
- Farm Essentials Profit: 94
- Total Segment Results: 59
Standalone Segment Revenue Q2 FY26:
- Living Essentials: 706
- Industrial Essentials: 668
- Total Segment Revenue: 1,374
- Less: Inter-segment revenue: 71
- Revenue from Operations: 1,303
Standalone Segment Results Q2 FY26:
- Living Essentials Profit: 192
- Industrial Essentials Profit: 31
- Total Segment Results: 223
Corporate Actions:
Dividend: Not specified in this announcement
Share Split/Bonus/Buyback: Not specified
Capital Raising: Not specified
Other Significant Information:
Operational Issue in Kenya: Tata Chemicals Magadi Limited (subsidiary) received a notice from the Ministry of Mining, Blue Economy and Maritime Affairs, Kenya directing suspension of mining operations and exports pending compliance review. This resulted in a loss of ₹21 crore during the quarter. The subsidiary has initiated legal proceedings and believes no impairment of assets is required as of September 30, 2026.
Segment Reorganization: Effective April 1, 2026, the Group reorganized reporting segments to: Living Essentials (Salt, Sodium bicarbonate, Prebiotics); Industrial Essentials (Soda ash, Silica, Industrial chemicals); Farm Essentials (Agrochemicals, Seeds).
Exceptional Items: For the year ended March 31, 2026, the Group recognized an impairment charge of ₹1,837 crore towards Goodwill for US operations and additional expenses of ₹65 crore relating to closure of Lostock operations in the UK.
Labour Code Impact: The Group has assessed the impact of newly notified Indian Labour Codes and disclosed incremental impact of ₹54 crore (consolidated) and ₹14 crore (standalone) for the year ended March 31, 2026, presented as exceptional items.
Entities in Consolidation: The consolidated results include Tata Chemicals Limited (holding company) and 27 subsidiaries, joint ventures, and associates including Tata Chemicals International Pte. Ltd., Rallis India Limited, Tata Chemicals Europe Limited, and Tata Chemicals Magadi Limited.